0001209191-23-024305.txt : 20230414 0001209191-23-024305.hdr.sgml : 20230414 20230414161439 ACCESSION NUMBER: 0001209191-23-024305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230412 FILED AS OF DATE: 20230414 DATE AS OF CHANGE: 20230414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SACHS BRUCE I CENTRAL INDEX KEY: 0001197036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 23821307 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-12 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197036 SACHS BRUCE I C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVE BOSTON MA 02210 1 0 0 0 1 Common Stock 2023-04-12 4 M 0 21300 72.14 A 62510 D Common Stock 2023-04-12 4 S 0 2917 325.65 D 59593 D Common Stock 2023-04-12 4 S 0 10357 326.46 D 49236 D Common Stock 2023-04-12 4 S 0 8026 327.48 D 41210 D Common Stock 2023-04-13 4 G 0 1210 0.00 D 40000 D Stock Option (Right to Buy) 72.14 2023-04-12 4 M 0 21300 0.00 D 2024-05-31 Common Stock 21300 0 D Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 11/04/2022. Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $325.65 (range $325.00 to $325.99). Open market sales reported on this line occurred at a weighted average price of $326.46 (range $326.00 to $326.97). Open market sales reported on this line occurred at a weighted average price of $327.48 (range $327.00 to $327.93). Fully vested /s/Christiana Stevenson, Attorney-in-Fact 2023-04-14